13 Mar 2025
Q3 Earnings call FY24/25
22 Jan 2025
Redeye Theme: Fight Cancer
Watch the recording of the presentation here:
12 Dec 2024
Q2 Earnings call FY24/25
Watch the video here
Presenters were:
Anders Rylander, CEO
Hector Tamburini, Head of US Operations
Henrik Winther, SVP Business Development
Anders Morén, CFO
12 Sep 2024
Q1 Earnings call FY24/25
Watch the video here
Presenters were:
Anders Rylander, CEO
Anders Morén, CFO
Hector Tamburini, Head of US Operations
Henrik Winther, SVP Business Development
18 Jun 2024
Q4 Earnings call FY23/24
Presentation and written answers from the Q&A session: here
Presenters were:
Anders Rylander, CEO
Anders Morén, CFO
Hector Tamburini, Head of US Operations
Henrik Winther, SVP Business Development
24 Apr 2024
RedEye Interview
See the interview by RedEye journalist Johan Unnerus based on the announcement that Biovica is doing a cost reduction program in Sweden and the US!
10 Apr 2024
Invest in Oncology
See the presentation from the recent Investor Day by CORD Communications and financialhearings.com
To see the presentation: Click here
14 Mar 2024
Q3 Earningscall
Hear about the sales uptake in the US and our recent MSA Pharma contracts and order intake.
Please click the image to watch the recording!
8 Dec 2023
Carlsquare Investor Day
Carlsquare brought together Life Science investors for a day of presentations. 20 min + 10 min questions for each company participating. Here is the recording from our presentation.
Please click the image to watch the recording!
7 Dec 2023
CEO Interview
See the video interview – it’s in Swedish!
Biovica är i full gång med lanseringen av sitt cancertest DiviTum TKa för att bättre och snabbare prediktera och monitorera behandlingseffekt. Efter flertalet avtal i Europa och USA siktas på företrädesemission av units för att finansiera fortsatta marknadssatsningar. BioStock har pratat med vd Anders Rylander för att få hans tankar kring lansering och företrädesemissionen.
30 Nov 2023
RedEye Interview with senior management
Watch the Streaming from Nov 30th, 2023
28 Nov 2023
Q2 Earnings Call FY23/24
Download the presentation and watch the recording here: Biovica International AB – Financial reports
Presenters are:
Anders Rylander, CEO
Warren Cresswell, President of Americas
Henrik Winther, SVP Business Development
Anders Morén, CFO
27 Nov 2023
CEO Anders Rylander presents at STORA AKTIEDAGARNA
See the recording, where Aktiespararna brought together around 50 small and large Nordic companies for three packed days of investors presentations.
23 Nov 2023
CEO Anders Rylander at Redeye Life Science Day 2023 - Recording available
Redeye brought together 40+ Nordic companies for the Life Science Day, allowing investors, businesses, and experts co-create the industry’s future.
Watch our CEO Anders Rylander during the Redeye discussions.
18 min Recording: here
3 Oct 2023
Redeye Interview with Warren Cresswell, President of the Americas, Biovica
Discussion on pricing: Securing a Medicare (CMS) price for the US launch of our DiviTum® TKa test.
Redeye video
26 Sept 2023
Redeye Medtech & Diagnostics Seminar
Anders Rylander, CEO, presents (in Swedish) at the Redeye Medtech & Diagnostics Seminar
25 Sept 2023
RedEye Interview regarding Arizona agreement
Video interview with CEO Anders Rylander and President Americas Warren Cresswell
14 Sept 2023
Pareto Securities' 14th Annual Healthcare Conference
CEO Anders Rylander presents
Presentation.pdf
6 Sept 2023
Q1 Earnings call 2023
Recorded event
22 May 2023
Trading Direkt Healthcare
Video interview with CEO Anders Rylander and President Americas Warren Cresswell:
Link to the interview on Redeye
2022
SEB Healthcare Seminar
Interview with Anders Rylander, CEO
23 November 2022
Company Presentation
With CEO Anders Rylander
28 September 2022
Redeye Diagnostics Forum
With CEO Anders Rylander
13 of September 2022
ABGSC Investor Day
CEO Presentation
2 of September 2022
Redeye Theme: Late Stage Life Science 2022
Anders Rylander, CEO
1 September 2022
CEO interview by Redeye
With CEO Anders Rylander
31 August 2022
CEO presentation AGM
With CEO Anders Rylander
18 August 2022
Market update
FDA Clearance
19 May 2022
ABGSC Life Science Summit
Interview with Anders Rylander, CEO
8 December 2021
ABGSC Investor Day
With Anders Rylander, CEO
2021
Annual General Meeting
CEO’s presentation
2020
Redeye Interview with CEO Anders Rylander
CEO’s presentation
6 mars 2020
Nordnet Nordic Invest, Capital Markets Seminar
28 January 2020
Aktiedagen Lund
Aktiespararna
28 January 2020
Panelsamtal: Framtidens behandling av cancer på Aktiedagen
i Lund
24 January 2020
Pareto Securities life science analytiker går igenom Biovica
4 november 2019
Stora Aktiedagen
i Göteborg
19 September 2019
Update on clinical development progress
Audiocast
5 September 2019
Pareto Securities’ 10th Annual Health Care Conference
in Stockholm
2018
Stora Aktiedagen
2018
ProHearings
>4,500
Numbers of patients in studies
28
Publications
22
Pharma Projects